Thanks for sharing @JosephHabibi_MD . Really pleased to have been able to contribute to this 🇬🇧 🇺🇸 collaborative effort coordinated by @MayoClinicGIHep
Published in @AGA_CGH. Using cluster analysis, we identified 4 new fecal incontinence phenotypes linked to QoL and anorectal function. Hopefully this approach will support more personalised therapy. Work from my time at @MayoClinicGIHep.
🔗 https://t.co/2ruRbO0TXO
Nice to see this article in print… deep gratitude to Adil Bharucha for introducing me to lower GI motility. More fecal (faecal is obviously the correct [UK] spelling 😅) incontinence papers soon…
🆕🔥Development & validation of a #BowelDiary for #FecalIncontinence‼️
🎯Significant agreement between characteristics of FI recorded with diary & questionnaire👏
✅Bowel diaries provide a simple & valuable tool for clinical practice & research studies💡
👉https://t.co/BL3gHqy4Cg
A wonderful evening with #Editorial team at #DDW2025@DDWMeeting@AmerGastroAssn‼️
It was a pleasure to finally meet in person & celebrate collective spirit that drives our editorial work forward👏
Such an incredible team🙏
✅️Advancing growth & impact of @NGMJournal 🎉
🆕🔥Clinical characteristics & outcomes of patients with Rome IV #FunctionalDyspepsia who consume #opioids: A Real-World Study‼️
✅1 in 3 outpatients consume opioids
🎯Opioid cessation alongside a neuromodulator improved GI symptoms
👉https://t.co/3abLtYdFk2
@esnm_eu@ANMSociety
It's always good to evaluate the performance of the @RomeFoundation diagnostic criteria, as per this 🔝 editorial by @ThisIsButt & @maura_corsetti in @APandT
🔓https://t.co/GpR1umTNzW
But isn't it high time we have a fundamental discussion about what #IBS really is?
#GItwitter